Electrophysiological characterization of a Cav3.2 calcium channel missense variant associated with epilepsy and

Robin N Stringer1,2, Leos Cmarko2,3,4, Gerald W Zamponi5

  • 1Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

Molecular Brain
|September 22, 2023
PubMed

Insights

A CACNA1H gene mutation (R132H) linked to epilepsy and hearing loss shows minor T-type calcium channel gating changes. Further research is needed to understand how these biophysical alterations contribute to the disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Biophysics

Background:

  • T-type calcium channelopathies are human disorders linked to mutations in T-type calcium channel genes.
  • A novel CACNA1H gene mutation (R132H) was recently identified in a patient with epilepsy and sensorineural hearing loss.

Observation:

  • The R132H mutation affects the Cav3.2 T-type calcium channel, located in the second transmembrane helix.
  • Electrophysiological characterization was performed using whole-cell patch clamp recordings in tsA-201 cells.

Findings:

  • The R132H mutation caused minor alterations in channel gating, including increased T-type current density and slower recovery from inactivation.
  • The mutated Cav3.2 channel exhibited enhanced sensitivity to external pH changes.

Implications:

  • The precise contribution of these biophysical changes and altered pH sensitivity to the observed pathogenicity requires further investigation.
  • Analyzing additional CACNA1H variants associated with similar pathologies is crucial for a comprehensive understanding.